SG11202004765XA - Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(n-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation - Google Patents

Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(n-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation

Info

Publication number
SG11202004765XA
SG11202004765XA SG11202004765XA SG11202004765XA SG11202004765XA SG 11202004765X A SG11202004765X A SG 11202004765XA SG 11202004765X A SG11202004765X A SG 11202004765XA SG 11202004765X A SG11202004765X A SG 11202004765XA SG 11202004765X A SG11202004765X A SG 11202004765XA
Authority
SG
Singapore
Prior art keywords
preparation
methylpropionic acid
deuterated
methylamino
amino
Prior art date
Application number
SG11202004765XA
Other languages
English (en)
Inventor
Aleksei Valerievich Lesiv
Pavel Evgenievich Ivashkin
Mikhail Vladimirovich Gulyaev
Evgeniya Olegovna Dorofeeva
Aleksei Viktorovich Kosenkov
Mikhail Valentinovich Kiselevsky
Vladimir Ivanovich Polshakov
Original Assignee
Solvex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvex Llc filed Critical Solvex Llc
Publication of SG11202004765XA publication Critical patent/SG11202004765XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Signal Processing (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
SG11202004765XA 2017-11-21 2017-11-21 Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(n-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation SG11202004765XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2017/000870 WO2019103636A1 (ru) 2017-11-21 2017-11-21 Препарат для магнитно-резонансной диагностики онкологических заболеваний, содержащий дейтерированную 2-амино-2-метилпропионовую кислоту и/или 2-(n-метиламино)-2-метилпропионовую кислоту, и способ диагностики с использованием этого препарата

Publications (1)

Publication Number Publication Date
SG11202004765XA true SG11202004765XA (en) 2020-06-29

Family

ID=66630775

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004765XA SG11202004765XA (en) 2017-11-21 2017-11-21 Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(n-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation

Country Status (11)

Country Link
US (1) US12082918B2 (zh)
EP (1) EP3714783B1 (zh)
JP (1) JP7252653B2 (zh)
KR (2) KR102441674B1 (zh)
CN (1) CN111655145B (zh)
AU (1) AU2017440592B2 (zh)
CA (1) CA3083111C (zh)
EA (1) EA202091298A1 (zh)
IL (1) IL274787B1 (zh)
SG (1) SG11202004765XA (zh)
WO (1) WO2019103636A1 (zh)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371611A (en) * 1978-08-07 1983-02-01 W. R. Grace & Co. Enzymatic diagnostic composition
US5042488A (en) 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US6574496B1 (en) 1999-05-19 2003-06-03 Amersham Health As Magnetic resonance imaging
EP1499584B1 (en) * 2002-04-30 2010-08-18 Emory University Tumor imaging compounds
US20030211036A1 (en) 2002-05-07 2003-11-13 Hadassa Degani Method and apparatus for monitoring and quantitatively evaluating tumor perfusion
WO2006011810A2 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
US20070104648A1 (en) * 2005-11-09 2007-05-10 Glyconix Corporation Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy
CA2722344A1 (en) * 2008-04-14 2009-10-22 Emory University Imaging agents
WO2010033511A1 (en) * 2008-09-16 2010-03-25 Concert Pharmaceuticals, Inc. Deuterated 2-amino-3-hydroxypropanoic acid derivatives
US10646594B2 (en) 2009-06-19 2020-05-12 Case Western Reserve University Deuterated metabolic water precursor for detecting and treating diseased tissue

Also Published As

Publication number Publication date
JP7252653B2 (ja) 2023-04-05
KR20200100079A (ko) 2020-08-25
IL274787A (en) 2020-07-30
WO2019103636A1 (ru) 2019-05-31
IL274787B1 (en) 2024-09-01
EP3714783B1 (en) 2024-08-14
CA3083111A1 (en) 2019-05-31
AU2017440592B2 (en) 2022-06-30
EP3714783A1 (en) 2020-09-30
EA202091298A1 (ru) 2020-10-05
KR20220054445A (ko) 2022-05-02
CN111655145B (zh) 2023-12-26
US20200352472A1 (en) 2020-11-12
AU2017440592A1 (en) 2020-07-02
CA3083111C (en) 2022-09-20
KR102522843B1 (ko) 2023-04-18
EP3714783A4 (en) 2021-05-19
KR102441674B1 (ko) 2022-09-08
JP2021504472A (ja) 2021-02-15
CN111655145A (zh) 2020-09-11
US12082918B2 (en) 2024-09-10

Similar Documents

Publication Publication Date Title
GB2555890B (en) System and method for magnetic resonance imaging
EP3216392A4 (en) Brain disease diagnosis assistance system, brain disease diagnosis assistance method, and program
PL3391041T3 (pl) Automatyczny kliniczny układ i sposób diagnostyczny
EP3405896A4 (en) SYSTEMS AND METHODS FOR ENHANCING DIAGNOSIS OF DISEASE
EP3110327A4 (en) Methods for assessing health conditions using single coil magnetic induction tomography imaging
EP3471608A4 (en) MAGNETIC RESONANCE SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSIS OF PAIN OR INFECTIONS RELATED TO PROPIONIC ACID
PT3527552T (pt) Derivado fundido tricíclico de -aminoácido, seu método de preparação, e sua utilização médica
EP3324844A4 (en) System and method for magnetic resonance imaging
EP3295200A4 (en) Systems and methods for diffusion-weighted multi-spectral magnetic resonance imaging
EP3192886A4 (en) Device for fixing biological soft tissue, and method for producing same
EP3302262A4 (en) Head coil and magnetic resonance imaging apparatus employing the same
EP3212080A4 (en) Magnetic resonance imaging patient temperature monitoring system and related methods
EP3366210A4 (en) Medical imaging device and magnetic resonance imaging device, and control method therefor
EP3607340A4 (en) SYSTEM AND METHOD FOR IMPROVED SPINE ECHO-BASED MAGNETIC RESONANCE IMAGING
EP3363466A4 (en) METHOD FOR PRODUCING CONTRASTING AGENTS FOR MAGNETIC RESONANCE IMAGING
GB2543961B (en) Magnetic resonance imaging matrix shim coil system and method
EP3402399A4 (en) MAGNETIC RESONANCE IMAGING APPARATUS AND METHOD THEREFOR
EP3119277A4 (en) Identifying different types of pain using magnetic resonance spectroscopy
EP3215008A4 (en) Magnetic resonance imaging apparatus and method
EP3139833A4 (en) Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography
EP3262590A4 (en) System and method for developing individual and team washroom compliance practices
EP3398511A4 (en) METHOD, DEVICE AND DEVICE FOR CHEMICAL SHIFT-CODED MAGNETIC RESONANCE IMAGING
EP3679388A4 (en) PROCESS FOR PERFORMING DIFFUSION-WEIGHTED MAGNETIC RESONANCE MEASUREMENTS
IL255432A0 (en) A Method for Optimizing the Predetermination of a Time Profile of Contrast Agent Concentration in Diagnostic Imaging Using a Magnetic Resonance System
EP3327733A4 (en) SUPERCONDUCTING WIRE, SUPER-CHARGE COIL, MRI AND NMR